his technology introduces a world-first atrial appendage fixation device for leadless pacemakers. Delivered via transfemoral access, it anchors securely in the right atrial appendage to prevent device dislodgement and perforation. The nitinol-based structure supports device replacement and is compatible with existing systems such as Medtronic Micra AV2 and Abbott Aveir DR. It is designed to be FDA-registered as an accessory, offering a safer and scalable solution for dual-chamber leadless pacing

This is the world’s first atrial appendage fixation device designed for leadless pacemakers. It enables safe anchoring in the right atrium, solving key issues of device dislodgement and cardiac perforation seen in current dual-chamber systems. The design is compatible with Micra AV2 and Aveir DR and allows future device replacement. Positioned as an FDA “accessory,” it supports regulatory acceleration and clinical adoption.

This novel atrial appendage fixation device enables safe right atrial implantation of leadless pacemakers. Compatible with systems like Micra AV2 and Aveir DR, it addresses a critical unmet need in dual-chamber pacing. With regulatory positioning as an FDA “accessory,” it offers accelerated commercialization and strong licensing potential. The technology is well-suited for integration or spin-off development targeting high-growth cardiovascular markets.